NCT06476106

Brief Summary

Venoconstrictive Thigh Cuffs (VTC) are being evaluated to determine the effectiveness at reversing the headward fluid shift that occurs during weightlessness. If successful, future studies may be done to implement these as a CM to SANS. To support this effort, participants will participate in 2 preflight study sessions consisting of a VTC fit check and a baseline data collection without and with the VTC donned. Participants will also participate in 3 inflight study sessions: a VTC fit check on flight day 30 (FD30) and two separate data collection sessions on flight day 45 (FD45) and 45 days before landing (R-45). During the two in-flight data collection days, participants will be studied before and for up to 6 hours after donning the VTC.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy

Timeline
49mo left

Started Mar 2023

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Mar 2023May 2030

Study Start

First participant enrolled

March 24, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 26, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 14, 2030

Last Updated

April 1, 2025

Status Verified

September 1, 2024

Enrollment Period

5.1 years

First QC Date

March 7, 2024

Last Update Submit

March 31, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Internal Jugular Vein (IJV) area

    Measured using Ultrasound.

    Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

  • IJV pressure

    Measured using the VeinPres device during Ultrasound.

    Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

  • Intraocular Pressure (IOP)

    Measured using the Pneumatonometer.

    Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

  • stroke volume

    Measured from data collected during Ultrasound.

    Thigh Cuff Measures 90 days before mission, after 45 days in mission, and 45 days before return

Study Arms (1)

Flight Thigh Cuff Crew Participants

EXPERIMENTAL

Participants will participate in 2 preflight study sessions consisting of a VTC fit check and a baseline data collection without and with the VTC donned. Participants will also participate in 3 inflight study sessions: a VTC fit check on flight day 30 (FD30) and two separate data collection sessions on flight day 45 (FD45) and 45 days before landing (R-45). During the two in-flight data collection days, participants will be studied before and for up to 6 hours after donning the VTC.

Device: Venoconstrictive Thigh Cuff (VTC)

Interventions

The VTC is an adjustable fabric cuff that is worn on the upper thighs to retain some fluid in the legs. It consists of wide straps and a buckle which allow it to be tightened, then velcro to secure the strap in the tightened position. There is also lacing that can be tightened for micro adjustments. Imbedded within the fabric strap is a bladder that is not used for increasing tightness but allows the pressure of the cuff to be measured and tracked.

Also known as: Thigh Cuff
Flight Thigh Cuff Crew Participants

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Astronauts participating in missions that are ≥2 months

You may not qualify if:

  • Having known allergies to proparacaine hydrochloride ophthalmic solution precludes participation in this study
  • Use of ethinyl estradiol Combined Oral Contraceptive (COC) pills precludes participation in this study
  • Having increased risk of venothromboembolism (VTE) based on preflight thrombosis/clotting related biomarkers precludes participation in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johnson Space Center, National Aeronautics and Space Administration

Houston, Texas, 77058, United States

Location

Study Officials

  • Brandon R Macias, PhD

    National Aeronautics and Space Administration (NASA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2024

First Posted

June 26, 2024

Study Start

March 24, 2023

Primary Completion (Estimated)

May 14, 2028

Study Completion (Estimated)

May 14, 2030

Last Updated

April 1, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations